1. Medtech Insight
  3. >>Diagnostics

Roche Launches COVID-19 Test For Cobas System; BioMérieux Plans Three COVID-19 Tests

 
• By Reed Miller

Roche announced that the US FDA has granted an Emergency Use Authorization for the cobas SARS-CoV-2 test for patients suspected to have COVID-19. bioMérieux is planning three COVID-19 tests.

Test tube with blood sample for COVID-19 test, novel coronavirus 2019 found in Wuhan, China
• Source: shutterstock.com

Roche Diagnostics Corp. and bioMerieux SA are joining the growing list of in vitro diagnostics makers addressing the COVID-19 pandemic.

On 13 March, Roche announced that the US Food and Drug Administration issued an Emergency Use Authorization (EUA) for its...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from In Vitro Diagnostics

More from Diagnostics